Supreme Court Examines Legal Shield for Sackler Family in $6bn Deal

The US Supreme Court is considering a bankruptcy deal for Purdue Pharma, the maker of OxyContin, which may shield the Sackler family from future lawsuits related to the opioid crisis. The deal, which granted the family immunity in civil cases, has faced criticism from US officials who argue it conflicts with bankruptcy law. While some families impacted by the drug support the deal, others want the Supreme Court to overturn it and hold the Sacklers accountable. The court's ruling will have significant implications for bankruptcy law and the ability of third parties to receive immunity in such cases.